SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-16-120478
Filing Date
2016-05-12
Accepted
2016-05-12 16:01:27
Documents
55
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a16-6672_110q.htm 10-Q 878564
2 EX-10.2 a16-6672_1ex10d2.htm EX-10.2 17992
3 EX-31.1 a16-6672_1ex31d1.htm EX-31.1 12404
4 EX-32.1 a16-6672_1ex32d1.htm EX-32.1 4774
  Complete submission text file 0001104659-16-120478.txt   3834339

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT catb-20160331.xml EX-101.INS 703655
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT catb-20160331.xsd EX-101.SCH 31082
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT catb-20160331_cal.xml EX-101.CAL 39282
8 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT catb-20160331_lab.xml EX-101.LAB 328605
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT catb-20160331_pre.xml EX-101.PRE 240288
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT catb-20160331_def.xml EX-101.DEF 120519
Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971
CATABASIS PHARMACEUTICALS INC (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37467 | Film No.: 161643658
SIC: 2834 Pharmaceutical Preparations